Paul M. Barr, MD

Articles

It is clear that chemoimmunotherapy has redefined the history of follicular lymphoma, producing survival rates measured in decades.

COUNTERPOINT: Can Chemotherapy Be Eliminated in the Treatment of Follicular Lymphoma?

Further prospective clinical trials in very elderly patients with DLBCL are clearly needed. Complementing the growing need for such trials, an evolving clinical trial infrastructure, geriatric oncology support, and novel therapeutics are making such studies feasible in the current era.

Author | Paul M. Barr, MD

Articles

New content coming soon, please check back later.